WallStreetZenWallStreetZen

NASDAQ: OVID
Ovid Therapeutics Inc Stock Ownership - Who owns Ovid Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ovid Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jeremy M. LevinCEO2024-03-1818,248$2.76
$50.36kBuy

1 of 1

OVID insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OVID insiders and whales buy or sell their stock.

OVID Shareholders

What type of owners hold Ovid Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Takeda Pharmaceutical Co Ltd10.61%7,531,996$8.66MInsider
Rubric Capital Management LP7.49%5,315,969$6.11MInstitution
Matthew During6.72%4,772,429$5.49MInsider
Madison Avenue Partners LP5.75%4,082,100$4.69MInstitution
Blackrock Inc5.63%3,992,346$4.59MInstitution
Bvf Inc5.43%3,853,818$4.43MInstitution
Jeremy M. Levin5.15%3,652,176$4.20MInsider
Vanguard Group Inc4.35%3,089,393$3.55MInstitution
Artal Group Sa3.52%2,500,000$2.88MInstitution
Acadian Asset Management LLC2.35%1,664,552$1.91MInstitution

1 of 3

OVID vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OVID54.24%23.70%Net Buying
CBUS19.09%80.91%Net BuyingNet Buying
MIST56.65%24.10%
SLS6.31%11.97%Net Selling
IKNA60.10%18.22%
View Top Biotech Stocks

Ovid Therapeutics Stock Ownership FAQ

Who owns Ovid Therapeutics?

Ovid Therapeutics (NASDAQ: OVID) is owned by 54.24% institutional shareholders, 23.70% Ovid Therapeutics insiders, and 22.06% retail investors. Takeda Pharmaceutical Co Ltd is the largest individual Ovid Therapeutics shareholder, owning 7.53M shares representing 10.61% of the company. Takeda Pharmaceutical Co Ltd's Ovid Therapeutics shares are currently valued at $8.51M.

If you're new to stock investing, here's how to buy Ovid Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.